![]() |
|
|


Department of Public Health, Gifu University School of Medicine, Gifu 500-8705, Japan;
*
Internal Medicine of Matsunami General Hospital, Gifu, Japan; and
The Third Department of Internal Medicine, Gifu University School of Medicine, Gifu 500-8705, Japan
2To whom correspondence should be addressed. E-mail: chisato{at}cc.gifu-u.ac.jp.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: soybeans isoflavones homocysteine premenopausal women
An elevated blood homocysteine concentration has been shown to be an independent risk factor for cardiovascular disease (1 ). Several studies have identified factors that are associated with homocysteine level in the general population (2 10 ). Established determinants of blood homocysteine include folate and vitamin B-12 status and serum creatinine concentration (10 ); this is expected because they serve as cofactors in the enzymatic pathway of homocysteine metabolism (11 ).
A recent study reported by Bazzano et al. (12 ) has shown that the consumption of legumes, which are high in bean protein, was significantly inversely associated with the risk of coronary heart disease. Soybeans are an excellent source of folate. It is possible that soy intake reduces the serum homocysteine concentration, which can lead to a decreased risk of coronary heart disease. However, there is a possibility that soy intake raises the serum homocysteine concentration because soybeans are also a unique dietary source of a group of phytochemicals called isoflavones. Although isoflavones are structurally similar to estrogens, it is hypothesized that isoflavones exert antiestrogenic effects in a high estrogen environment, such as in premenopausal women, and estrogenic effects in a low estrogen environment, such as in postmenopausal women (13 ). Blood homocysteine concentration is related to estrogen status. Premenopausal women or women who are on hormone replacement therapy have lower homocysteine concentrations than postmenopausal women (14 ,15 ). Therefore, soy or isoflavone intake in premenopausal women may hinder the beneficial effect of their endogenous estrogen status on homocysteine concentration.
To our knowledge, two intervention studies that examined the effects of soy protein on serum biomarkers have included measurements of serum homocysteine in diabetic subjects (16 ) and hypercholesterolemic subjects (17 ). In both studies, there was a decreased plasma homocysteine concentration with soy protein intake compared with casein intake, suggesting a novel, possibly antiatherosclerotic effect of dietary soy. However, the subjects of these studies were men or postmenopausal women. Also, the differences in amino acid composition, including that of methionine, one of the principal dietary precursors of homocysteine, of casein and soy protein may account for the findings.
In the present cross-sectional study, we examined the relationship between soy intake and serum homocysteine concentration in premenopausal Japanese women considering folate, methionine, vitamin B-6 and vitamin B-12 status. A recent update of the Japanese food composition tables enabled us to measure dietary intakes of folate and vitamins B-6 and B-12.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Diet was assessed by a semiquantitative food-frequency questionnaire. The women were asked to indicate the average frequency that they consumed 169 food items during the year before the study and the usual serving size of each item. We included nine food items for soy products (miso soup, tofu, deep-fried tofu, fried bean curd, dried bean curd, fermented soy beans, houba-miso, soymilk and boiled soybeans). Soy product intake, as the total amount (g/d) of soy products, was calculated as the sum of these nine food items. Soy protein intake (g/d) was also calculated as the sum of the protein included in these food items. Isoflavone intake (mg/d) from soy products was estimated using isoflavone concentration in these soy foods (18 ). The intakes of foods and nutrients were estimated from the frequency of ingestion and portion size using the Japanese Standard Tables of Food Composition, fourth and fifth editions, published by the Science and Technology Agency of Japan (19 ). The Japanese food composition tables are incomplete for amino acid compositions of some foods. When the values were missing for a certain food, they were substituted by those of another nutritionally comparable food. Detailed information on the questionnaire, including its validity and reproducibility, has been described (20 ,21 ). For example, the Spearman correlation coefficient comparing estimates of soy product intake from this questionnaire with the estimates from 12 daily diet records kept over a 1-y period was 0.71. The corresponding figures for folate, methionine and vitamins B-6 and B-12 were 0.45, 0.61, 0.59 and 0.24, respectively.
A fasting blood sample was collected from each subject between 9 and 10 AM. The samples were stored at -80°C until assayed. Serum homocysteine was determined by HPLC using the fluorescent conjugate (22 ). Serum folate was measured with a radioassay (23 ). Serum creatinine was determined with standard automated clinical chemistry laboratory technique (24 ). All measurements were conducted at SRL, Inc. (Tokyo, Japan). The intra-assay and interassay CVs were 1.1% and 3.5% for homocysteine, 7.5% and 11.1% for folate and 1.3% and 2.3% for creatinine, respectively.
This study was approved by the local institutional review board.
For statistical analysis, we excluded women who were taking hormone replacement therapy or other hormones (n = 11) and who had a history of cancer (n = 10), ischemic heart disease (n = 1) and endogenous diseases such as diabetes mellitus (n = 9). Of the 260 eligible women, serum creatinine concentrations were measured for 207 women who chose program courses including this measurement; 201 had sufficient sera available for the measurement of serum folate and homocysteine. Their ages ranged from 20 to 54 y.
Spearman correlation coefficients were used to calculate the associations of dietary soy with serum homocysteine and folate. Intakes of soy products and the individual nutrient were log-transformed and adjusted for total energy intake using the method proposed by Willett (25 ). Previous studies have suggested that age, body size, education, smoking, alcohol use, coffee consumption and serum creatinine concentrations are associated with blood homocysteine concentration. The effects of these potential confounders were examined by including them into the models as covariates. Significant difference was declared at P = 0.05. All of the statistical analyses were performed using SAS programs (26 ).
| RESULTS |
|---|
|
|
|---|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Soy intake was significantly inversely correlated with serum folate, and an adjustment for folate status or dietary vitamin B-6 attenuated the correlation between soy intake variables and serum homocysteine. This may suggest that the folate or vitamin B-6 contained in soy products accounts for the apparent association between dietary soy and serum homocysteine concentration. However, it is possible that some other components of soybeans are related to decreased serum homocysteine concentration. Soy products are also rich in minerals, such as iron, zinc, calcium, phosphorus and potassium. The dietary or plasma concentration of these minerals has been inversely associated with serum homocysteine concentration in some studies (3 ,28 ) as well as in the present study (data not shown). Because of strong correlations among intakes of folate, vitamins and minerals when soy products are consumed, it is difficult to associate specific components of soybeans with a decreased serum homocysteine concentration. It is also impossible to entirely rule out confounding with serum folate or intake of folate, vitamin B-6, minerals or other nutrients as an explanation of our finding.
We speculated that the presence of folate or vitamin B-6, if not other components in soybeans, might offset the homocysteine concentration raising effect of soy isoflavones. However, we considered whether soy isoflavones can increase the serum homocysteine concentration in premenopausal women through the antiestrogenic effect. Studies on endogenous estrogen and homocysteine concentrations are scarce. Wouters et al. (29 ) have reported that plasma homocysteine concentration after methionine loading was negatively correlated with serum estradiol concentration. Our previous cross-sectional and intervention studies have shown that soy intake decreases serum estrogen concentrations in premenopausal women (20 ,30 ). However, a decreased serum estrogen concentration may not necessarily lead to a decrease in homocysteine concentration. Considering that the observed correlation between soy isoflavone intake and serum homocysteine concentration was attenuated but remained inverse after adjustment for folate status, we cannot rule out the possibility that dietary soy has an estrogenic effect on homocysteine metabolism in premenopausal women.
Although the present study had limitations in terms of inferring to what extent each component of soy products, such as folate and isoflavones is related to serum homocysteine concentration, we obtained results that do not indicate a homocysteine concentration raising effect of this biochemical complex in premenopausal women. The results instead suggested a favorable effect of soy products as a food group in regard to homocysteine metabolism. There is growing interest in the potential health effects of soy or soy isoflavones. It is worth focusing on this food group to study both the risks and benefits of soy isoflavones. In addition, recent studies on diet and cardiovascular disease risk factors, such as hypertension, have considered the benefits of foods instead of emphasizing single nutrients (31 ). Although soybeans and soy products are biochemically complex, information about relationships of this food group to diseases or health-related conditions would help consumers to make healthy food choices.
In the present study, the estrogen status of some women may be similar to that of postmenopausal women. Inclusion of these women may have favored the inverse correlation between soy intake and serum homocysteine concentration. However, restricting the study subjects to women who were aged 50 y old or younger and had had a menstrual cycle in the past 3 mo (n = 187) did not substantially alter the results (r = -0.14, P = 0.06 for total soy products, r = -0.15, P = 0.04 for soy protein and r = -0.15, P = 0.046 for soy isoflavone in relation to serum homocysteine concentration).
Our dietary questionnaire was designed to measure an individuals relative intakes of foods and nutrients rather than absolute values. The intakes of folate and vitamins B-6 and B-12 may have been overestimated by the questionnaire because in the validity study, these estimates from the questionnaire were 15% (for vitamin B-12) to 26% (for folate) higher than those estimated from the 12 daily diet records over 1 y. On the other hand, the data presented for soy products may have been underestimated because soy product intake estimated from the questionnaire was 20% lower than that estimated from the 12 daily diet records. Although we estimated that 12.3% of total folate intake and 5.9% of total vitamin B-6 intake would be derived from soy products in our study subjects, these values are very likely to be underestimates.
We could not measure serum estrogen concentrations because blood samples were not drawn from the subjects on the same day of their menstrual cycle. Tallova et al. (32 ) reported a change in blood homocysteine concentration during the menstrual cycle. In the present study, adjustment for the day of blood draw in relation to the menstrual cycle did not substantially alter the results (r = -0.13, P = 0.08 for total soy products, r = -0.14, P = 0.046 for soy protein and r = -0.14, P = 0.06 for soy isoflavones in relation to serum homocysteine concentration). To our knowledge, none of the previous studies on lifestyle and homocysteine concentration in premenopausal women have included the measurements of serum estrogens. Interrelationships among dietary soy and endogenous estrogen and homocysteine concentrations should be elucidated in future studies.
| FOOTNOTES |
|---|
Manuscript received 28 September 2002. Initial review completed 25 October 2002. Revision accepted 21 November 2002.
| LITERATURE CITED |
|---|
|
|
|---|
1. Ford, E. S., Smith, S. J., Stroup, D. F., Steinberg, K. K., Mueller, P. W. & Thacker, S. B. (2002) Homocysteine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int. J. Epidemiol. 31:59-70.
2. Nygård, O., Vollset, S. E., Refsum, H., Stensvold, I., Tverdal, A., Nordrehaug, J. E., Ueland, P. M. & Kvale, G. (1995) Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. J. Am. Med. Assoc. 274:1526-1533.
3. Bates, C. J., Mansoor, M. A., Van der Pols, J., Cole, T. J. & Finch, S. (1997) Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over. Eur. J. Clin. Nutr. 51:691-697.[Medline]
4. Nygård, O., Refsum, H., Ueland, P. M., Stenvold, I., Nordrehang, J. E., Kvåle, G. & Vollset, S. E. (1997) Coffee consumption and plasma total homocysteine: the Hordaland Homocysteine Study. 65:136-143.
5. Nygård, O., Refsum, H., Ueland, P. M. & Vollset, S. E. (1998) Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am. J. Clin. Nutr. 67:263-270.[Abstract]
6. Giles, W. H., Kittner, S. J., Croft, J. B., Wozniak, M. A., Wityk, R. J., Stern, B. J., Sloan, M. A., Price, T. R., McCarter, R. J., Macko, R. F., Johnson, C. J., Feeser, B. R., Earley, C. J., Buchholz, D. W. & Stolley, P. D. (1999) Distribution and correlates of elevated total homocysteine: the Stroke Prevention in Young Women Study. Ann. Epidemiol. 9:307-313.[Medline]
7. Stolzenberg-Solomon, R. Z., Miller, E. R., III, Maguire, M. G., Selhub, J. & Appel, L. J. (1999) Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population. Am. J. Clin. Nutr. 69:467-475.
8. Rasmussen, L. B., Ovesen, L., Bülow, I., Knudsen, N., Laurberg, P. & Perrild, H. (2000) Folate intake, lifestyle factors, and homocysteine concentrations in younger and older women. Am. J. Clin. Nutr. 72:1156-1163.
9. de Bree, A., Verschuren, W. M. M., Blom, H. J. & Kromhout, D. (2001) Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am. J. Epidemiol. 154:150-154.
10. Jacques, P. F., Bostom, A. G., Wilson, P. W. F., Rich, S., Rosenberg, I. H. & Selhub, J. (2001) Determinants of plasma total homocysteine concentration in the Framingham offspring cohort. Am. J. Clin. Nutr. 73:613-621.
11. McKinley, M. C. (2000) Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease. Proc. Nutr. Soc. 59:221-237.[Medline]
12. Bazzano, L. A., He, J., Ogden, L. G., Loria, C., Vupputuri, S., Myers, L. & Whelton, P. K. (2001) Legume consumption and risk of coronary heart disease in US men and women. Arch. Intern. Med. 161:2573-2578.
13. Messina, M. (1999) Legumes and soybeans: overview of their nutritional profiles and health effects. Am. J. Clin. Nutr. 70(Suppl.):439S-450S.
14. Lien, E. A., Anker, G., Lønning, P. E., Refsum, H. & Ueland, P. M. (1997) Effects of hormones on the plasma levels of the atherogenic amino acid homocysteine. Biochem. Soc. Trans. 25:33-35.[Medline]
15. Morris, M. S., Jacques, P. F., Selhub, J. & Rosenberg, I. H. (2001) Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 152:140-148.
16. Hermansen, K., Carstensen, M., Søndergaard, M., Brock, B. & Høie, L. (2001) Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24:228-233.
17. Tonstad, S., Smerud, K. & Høie, L. (2002) A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am. J. Clin. Nutr. 76:78-84.
18. Wakai, K., Egami, I., Kato, K., Kawamura, T., Tamakoshi, A., Lin, Y, Nakayama, T., Wada, M. & Ohno, Y. (1999) Dietary intake and sources of isoflavones among Japanese. Nutr. Cancer 33:139-145.[Medline]
19. The Science and Technology Agency of Japan (2001) Standard Tables of Food Composition in Japan 5th rev ed. 2001 Kagawa Nutrition University Press Tokyo, Japan.
20. Nagata, C., Kabuto, M., Kurisu, Y. & Shimizu, H. (1997) Decreased serum estradiol concentration associated with high dietary intake of soy products in premenopausal Japanese women. Nutr. Cancer 29:228-233.[Medline]
21. Shimizu, H., Ohwaki, A., Kurisu, Y., Takatsuka, N., Kawakami, N., Ido, M., Nagata, C. & Inaba, S. (1999) Validity and reproducibility of a quantitative food frequency questionnaire for a cohort study in Japan. Jpn. J. Clin. Oncol. 29:38-44.
22. Araki, A. & Sako, Y. (1987) Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 422:43-52.[Medline]
23. Ishiwata, Y., Endo, N., Ikeda, R. & Yasuda, K. (1995) Fundamental studies on the determination of serum vitamin B-12 and folate using chemilumianalyzer ACS-180. Jpn. J. Clin. Lab. Automat. 20:29-37.
24. Asano, K., Iwata, H., Fijimura, K., Ikeda, M., Sugimoto, Y., Matsubara, A., Yano, K., Irisawa, H., Kono, F. & Kanbe, M. (1992) Automated microanalysis of creatinine by coupled enzyme reactions. Hiroshima J. Med. Sci. 41:1-5.[Medline]
25. Willett, W. (1990) Implications of total energy intake for epidemiological analyses. Willett, W eds. Nutritional Epidemiology 1990:245-270 Oxford University Press Oxford. .
26. SAS Institute Inc. (1989) SAS/STAT Users Guide, Version 6.04. 1989 SAS Institute Inc. Cary, NC.
27. Selhub, J., Jacques, P. F., Wilson, P. W., Rush, D. & Rosenberg, I. H. (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J. Am. Med. Assoc. 270:2693-2698.[Abstract]
28. Shimakawa, T., Nieto, F. J., Malinow, M. R., Chambless, L. E., Schreiner, P. J. & Szklo, M. (1997) Vitamin intake: a possible determinant of plasma homocysteine among middle-aged adults. Ann. Epidemiol. 7:285-293.[Medline]
29. Wouters, M. G. A. J., Moorrees, M. T. E. C., Van der Mooren, M. J., Blom, H. J., Boers, G. H. J., Schellekens, L. A., Thomas, C. M. G. & Eskes, T. K. A. B. (1995) Plasma homocysteine and menopausal status. Eur. J. Clin. Invest. 25:801-805.[Medline]
30. Nagata, C., Takatsuka, N., Inaba, S., Kawakami, N. & Shimizu, H. (1998) Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women. J. Natl. Cancer Inst. 90:1830-1835.
31. Hermansen, K. (2000) Diet, blood pressure and hypertention. Br. J. Nutr. 83:S113-S119.
32. Tallova, J., Tomandl, J., Bicikova, M. & Hill, M. (1999) Changes of plasma total homocysteine levels during the menstrual cycle. Eur. J. Clin. Invest. 29:1041-1044.[Medline]
This article has been cited by other articles:
![]() |
L. N Hanson, H. M Engelman, D L. Alekel, K. L Schalinske, M. L Kohut, and M. B Reddy Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 774 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L Lutsey, L. M Steffen, H. A Feldman, D. H Hoelscher, L. S Webber, R. V Luepker, L. A Lytle, M. Zive, and S. K Osganian Serum homocysteine is related to food intake in adolescents: the Child and Adolescent Trial for Cardiovascular Health Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1380 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Trock, L. Hilakivi-Clarke, and R. Clarke Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst, April 5, 2006; 98(7): 459 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Reimann, J. Dierkes, A. Carlsohn, D. Talbot, M. Ferrari, J. Hallund, W. L. Hall, K. Vafeiadou, U. Huebner, F. Branca, et al. Consumption of Soy Isoflavones Does Not Affect Plasma Total Homocysteine or Asymmetric Dimethylarginine Concentrations in Healthy Postmenopausal Women J. Nutr., January 1, 2006; 136(1): 100 - 105. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||